Ensho Joins Race To Develop An Oral Integrin Inhibitor For IBD

Start-Up Licensed Lead Drug From Eisai Subsidiary

Rocket launching from wood cube with business icon, Start-up, Creativity, Big idea, Business goals management, Investment
Ensho is launching with a new CEO coming from Telavant • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business